These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
602 related articles for article (PubMed ID: 14684847)
1. Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site. Petz LN; Ziegler YS; Schultz JR; Nardulli AM Mol Endocrinol; 2004 Mar; 18(3):521-32. PubMed ID: 14684847 [TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor alpha and activating protein-1 mediate estrogen responsiveness of the progesterone receptor gene in MCF-7 breast cancer cells. Petz LN; Ziegler YS; Loven MA; Nardulli AM Endocrinology; 2002 Dec; 143(12):4583-91. PubMed ID: 12446585 [TBL] [Abstract][Full Text] [Related]
3. Differential regulation of the human progesterone receptor gene through an estrogen response element half site and Sp1 sites. Petz LN; Ziegler YS; Schultz JR; Kim H; Kemper JK; Nardulli AM J Steroid Biochem Mol Biol; 2004 Feb; 88(2):113-22. PubMed ID: 15084343 [TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters. Matthews J; Wihlén B; Tujague M; Wan J; Ström A; Gustafsson JA Mol Endocrinol; 2006 Mar; 20(3):534-43. PubMed ID: 16293641 [TBL] [Abstract][Full Text] [Related]
5. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene. Manna PR; Eubank DW; Stocco DM Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133 [TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor alpha, fos-related antigen-2, and c-Jun coordinately regulate human UDP glucuronosyltransferase 2B15 and 2B17 expression in response to 17beta-estradiol in MCF-7 cells. Hu DG; Mackenzie PI Mol Pharmacol; 2009 Aug; 76(2):425-39. PubMed ID: 19487245 [TBL] [Abstract][Full Text] [Related]
7. ERalpha and AP-1 interact in vivo with a specific sequence of the F promoter of the human ERalpha gene in osteoblasts. Lambertini E; Tavanti E; Torreggiani E; Penolazzi L; Gambari R; Piva R J Cell Physiol; 2008 Jul; 216(1):101-10. PubMed ID: 18247370 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element. Uht RM; Anderson CM; Webb P; Kushner PJ Endocrinology; 1997 Jul; 138(7):2900-8. PubMed ID: 9202234 [TBL] [Abstract][Full Text] [Related]
9. The inhibitory activity of a transdominant c-jun mutant fused to the ligand binding domain of the estrogen receptor. Kim S; Brown PH; Birrer MJ Oncogene; 1996 Mar; 12(5):1043-53. PubMed ID: 8649795 [TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4. Zhao Y; Nichols JE; Valdez R; Mendelson CR; Simpson ER Mol Endocrinol; 1996 Nov; 10(11):1350-7. PubMed ID: 8923461 [TBL] [Abstract][Full Text] [Related]
11. Elevated connexin-43 expression in term human myometrium correlates with elevated c-Jun expression and is independent of myometrial estrogen receptors. Geimonen E; Boylston E; Royek A; Andersen J J Clin Endocrinol Metab; 1998 Apr; 83(4):1177-85. PubMed ID: 9543137 [TBL] [Abstract][Full Text] [Related]
12. Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis. Philips A; Chalbos D; Rochefort H J Biol Chem; 1993 Jul; 268(19):14103-8. PubMed ID: 8314777 [TBL] [Abstract][Full Text] [Related]
13. Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor A promoter. Petz LN; Nardulli AM Mol Endocrinol; 2000 Jul; 14(7):972-85. PubMed ID: 10894148 [TBL] [Abstract][Full Text] [Related]
14. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Smith LM; Wise SC; Hendricks DT; Sabichi AL; Bos T; Reddy P; Brown PH; Birrer MJ Oncogene; 1999 Oct; 18(44):6063-70. PubMed ID: 10557095 [TBL] [Abstract][Full Text] [Related]
15. Two proximal activating protein-1-binding sites are sufficient to stimulate transcription of the ovine follicle-stimulating hormone-beta gene. Strahl BD; Huang HJ; Pedersen NR; Wu JC; Ghosh BR; Miller WL Endocrinology; 1997 Jun; 138(6):2621-31. PubMed ID: 9165057 [TBL] [Abstract][Full Text] [Related]
16. Receptor-interacting protein 140 binds c-Jun and inhibits estradiol-induced activator protein-1 activity by reversing glucocorticoid receptor-interacting protein 1 effect. Teyssier C; Belguise K; Galtier F; Cavailles V; Chalbos D Mol Endocrinol; 2003 Feb; 17(2):287-99. PubMed ID: 12554755 [TBL] [Abstract][Full Text] [Related]
17. FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells. Philips A; Teyssier C; Galtier F; Rivier-Covas C; Rey JM; Rochefort H; Chalbos D Mol Endocrinol; 1998 Jul; 12(7):973-85. PubMed ID: 9658402 [TBL] [Abstract][Full Text] [Related]
18. Increase in messenger ribonucleic acid encoding the myometrial gap junction protein, connexin-43, requires protein synthesis and is associated with increased expression of the activator protein-1, c-fos. Piersanti M; Lye SJ Endocrinology; 1995 Aug; 136(8):3571-8. PubMed ID: 7628395 [TBL] [Abstract][Full Text] [Related]
19. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription. Bollig A; Miksicek RJ Mol Endocrinol; 2000 May; 14(5):634-49. PubMed ID: 10809228 [TBL] [Abstract][Full Text] [Related]
20. Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells. Zhao B; Yu W; Qian M; Simmons-Menchaca M; Brown P; Birrer MJ; Sanders BG; Kline K Mol Carcinog; 1997 Jul; 19(3):180-90. PubMed ID: 9254885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]